Rickets Due to Renal Tubular Abnormalities

Pediatric Bone: Biology & Diseases

Volumn , Issue , 2003, Pages 633-649

  Chesney, Russell W ^a   Jones, Deborah P ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33749331000     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012286551-0/50028-2     Document Type: Chapter

References (80)

1. Chesney R.W. Fanconi syndrome and renal tubular acidosis. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 2000, 340-343. Lippincott Williams & Wilkins, Philadelphia. 4th ed. M.J. Favus (Ed.).
2. Rao D., Parfitt A., Villanueva A., Dorman P., Kleerekoper M. Hypophosphatemic osteomalacia and adult Fanconi syndrome due to light chain nephropathy: Another form of oncogenous osteomalacia. Am. J. Med. 1987, 82:333-338.
3. Jones D., Chesney R.W. Tubular function. Pediatric Nephrology 1999, 59-82. Williams & Wilkins, Philadelphia. 4th ed. T.M. Barratt, E. Avner, W. Harmon (Eds.).
4. Carbajo E., Lopez J., Santos F., Ordonez F., Nino P., Rodriguez J. Histologic and dynamic changes induced by chronic metabolic acidosis in the rat growth plate. J.Am. Soc. Nephrol. 2000, 12:1228-1234.
5. Kreiger N., Sessler M., Bushinsky D. Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro. Am. J. Physiol. 1992, 262:F442-F448.
6. Sanchez C., Salusky I., Kuizon B., Abdella P., Juppner H., Goodman W. Growth of long bones in renal failure: Roles of hyperparathyroidism, growth hormone and calcitriol. Kidney Int. 1998, 54:1879-1887.
7. Baum M. The cellular basis of Fanconi syndrome. Hosp. Pract. 1994, November 15, 137-148.
8. Chesney R.W. Metabolic bone disease. Nelson Textbook of Pediatrics 2002, Saunders, Baltimore. R.E. Behrman, R. Kliegman, H.B. Jensen (Eds.).
9. Gaucher A., Thomas J., Netter P., Faure G. Osteomalacia, pseudosacroilitis and necrosis of the femoral heads in Fanconi syndrome in an adult. J.Rheumatol. 1981, 1981:512-515.
10. Brenton D., Isenberg D., Ainsworth D., Garrod P., Krywawyeh S., Stamp T. The adult presenting idiopathic Fanconi syndrome. J.Inherit. Metab. Dis. 1981, 4:211-215.
11. Chesney R.W., Harrison H. Fanconi syndrome following bowel surgery and hepatitis reversed by 25-hydroxycholecalciferol. J.Pediatr. 1975, 86:857-861.
12. Kitagawa T., Akatsuka A., Owada M., Mano T. Biologic and therapeutic effects of 1-alpha-hydroxycholecalciferol in different types of Fanconi syndrome. Contrib. Nephrol. 1980, 22:107-119.
13. Baran D., March T. Evidence for a defect in vitamin D metabolism in a patient with incomplete Fanconi syndrome. J.Clin. Endocrinol. 1984, 59:998-1001.
14. Chesney R.W. Noncystic inherited renal disease. Therapy in Nephrology and Hypertension 2002, Saunders, Philadelphia. H.F. Brady, C.M. Wilcox (Eds.).
15. Friedman A., Chesney R.W. Fanconi syndrome in renal transplantation. Am. J. Nephrol. 1981, 1:45-47.
16. Mckay C., Specker B., Chesney R.W. Bone and mineral metabolism during childhood. Favus & Coe 2002, Raven Press, Philadelphia. 2nd ed.
17. Steinberg R., Chesney R.W., Schulman J., Deluca H., Phelps M. Circulating vitamin D metabolites in nephro-pathic cystinosis. J.Pediatr. 1983, 120:592-594.
18. Muller D., Hoenderop J., van Os C., Bindels J. The epithelial calcium channel, ECaCl: Molecular details of a novel player in renal calcium handling. Am. J. Physiol. 2002, in press.
19. Zelikovic I. Molecular pathophysiology of tubular transport disorders. Pediatr. Nephrol. 2002, 16:919-935.
20. Aurbach G., Marx S., Spiegel A. Metabolic bone disease. Williams Textbook of Endocrinology 1991, 1752-1774. Saunders, New York. J.D. Wilson, D.W. Foster (Eds.).
21. Kalatzis V., Cherquil S., Jean G., Cordier B., Cochat P., Broyer M., Antignac C. Characterization of a putative founder mutation that accounts for the high incidence of cystinosis in Brittany. J.Am. Soc. Nephrol. 2001, 12:2170-2174.
22. Gahl W., Schneider J., Aula P. Lysosomal transport disorders: Cystinosis and sialic acid storage disorders. The Metabolic and Molecular Basis of Inherited Disease 1995, 3763-3797. McGraw-Hill, Philadelphia. 7th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
23. Gloneux F., Marie P., Pettifor J.M., Delvin E. Bone response to phosphate salts, ergocalciferol, calcitriol in hypopho-sphatemic vitamin D resistant rickets. N.Engl. J. Med. 1980, 303:1023-1030.
24. Bergeron M., Gougoux A., Noel J., Parent L. The renal Fanconi syndrome. The Metabolic and Molecular Bases of Inherited Disease 2001, 5023-5038. McGraw-Hill, New York. C. Scriver, A. Beaudet, D. Valle, W. Sly, B. Childs, K. Kinzler, B. Vogelstein (Eds.).
25. Rodriguez S., Houston I., Boichis H., Edelmann C.J. Calcium and phosphorus metabolism in the Fanconi syndrome. J.Clin. Endocrinol. Metab. 1968, 28:1555-1565.
26. Matos V., Van Melle G., Boulat O., Markert M., Bachmann C., Guignard J.P. Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population. J.Pediatr. 1997, 131:252-257.
27. Zelikovic I., Dabbagh S., Friedman A., Goelzer M., Ches-Ney R.W. Severe "renal osteodystrophy" without elevated serum immunoreactive parathyroid hormone (iPTH) concentrations in hypomagnesemia due to renal magnesium was. Pediatrics 1987, 79:403-409.
28. Bettinelli A., Basilico E., Metta G., Borella P., Jaeger P., Bianchetti M. Magnesium supplementation in Gitelman syndrome. Pediatr. Nephrol. 1999, 13:311-314.
29. Nicholson J., Jones C., Powell H., Walker R., Mccreche D. Familial hypomagnesemia-hypercalciuria leading to end-stage renal failure. Pediatr. Nephrol. 1995, 9:74-76.
30. 2+ resorption. Science 1999, 285:103-106.
31. Michelis M., Drash A., Linarelli L., De Rubertis F., Davis B. Decreased bicarbonate threshold and renal magnesium wasting in a sibship with distal renal tubular acidosis. Metabolism 1972, 21:905-920.
32. Simon D., Nelson-Williams C., Bia M., Ellison D., Karet F., Molina A., Vaarna I., Iwata F., Cushner H., Koolen M., Gainza F., Gitelman H., Lifton R. Gitelman's variant of Bart-ter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nature Genet. 1996, 12:24-30.
33. Lemmink H., Van Den Heuvel L., Van Dijk H., Merkx G., Smilde T., Taschner P., Monnens L., Hebert S., Knoers N. Linkage of Gitelman syndrome to the thiazide-sensitive sodium-chloride cotransporter gene with identification of mutations in Dutch families. Pediatr. Nephrol. 1996, 10:403-407.
34. Sutton R., Mavichak V., Halabe A., Wilkins G. Bartter's syndrome: Evidence suggesting a distal tubular defect in a hypocalciuric variant of the syndrome. Miner. Electrolyte Metab. 1992, 18:43-51.
35. Calo L., Punzi L., Semplicini A. Hypomagnesemia and chondrocalcinosis in Bartter's and Gitelman's syndrome: Review of the pathogenetic mechanisms. Am. J. Nephrol. 2000, 20:347-350.
36. Oktenli C. Renal magnesium wasting, hypomagnesemic hypocalcemia, hypocalciuria and osteopenia in a patient with glycogenosis type II. Am. J. Nephrol 2000, 20:412-417.
37. Cruz D., Shaer A., Bia M., Lifton R., Simon D. Gitelman's syndrome revisited: An evaluation of symptoms and health related quality of life. Kidney Int. 2001, 59.
38. Cole D. Inherited disorders of renal magnesium handling. J.Am. Soc. Nephrol. 2000, 11:1937-1947.
39. Geven W., Monnens L., Willems J., Buijs W., Ter Haar B. Renal magnesium wasting in two families with autosomal dominant inheritance. Kidney Int. 1987, 31:1140-1144.
40. Carpenter T., Key L. Disorders of the metabolism of calcium, phosphorus and other divalent ions. Pediatric Text-book of Fluids and Electrolytes 1990, 237-268. Williams & Wilkins, New York. I. Ichikawa (Ed.).
41. Aladjem M., Barr J., Lahat E., Bistritzer T. Renal and absorptive hypercalciuria: A metabolic disturbance with varying and interchanging modes of expression. Pediatrics 1996, 97:216-219.
42. Weisinger J. New insights into the pathogenesis of idiopathic hypercalciuria: The role of bone. Kidney Int. 1996, 49:1507-1518.
43. Pak C, Ohata M., Lawrence E., Snyder W. The hypercalciurias: Causes, parathyroid functions and idiopathic criteria. J.Clin. Invest. 1974, 54:387-400.
44. Coe F., Bushinsky D. Pathophysiology of hypercalciuria. Am. J. Physiol. 1984, 247:F1-F13.
45. Wills N., Fong P. C1C chloride channels in epithelia: Recent progress and remaining puzzles. News Physiol. Sci. 2001, 16:161-166.
46. Scheinmau S. X-linked hypercalciuric nephrolithiasis: Clinical syndromes and chloride channel mutations. Kidney Int. 1998, 53:3-17.
47. Piwon N., Gunther W., Schwake M., Bosl M., Jentsch T. C1C-5 CI channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 2000, 408.
48. Jentsch T., Friedrich T., Schriever A., Yamada H. The C1C chloride channel family. Pflugers Arch. 1999, 437:783-795.
49. Wang S., Devuyst O., Courtoy P., Wang X.-T., Wang H., Wang Y., Thakker R., Guggino S., Guggino W. Mice lacking renal chloride channel, C1C-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor mediated endocytosis. Hum. Mol Genet. 2000, 9:2937-2945.
50. Simon D., Bindra R., Mansfield T., Nelson-Williams C., Men-Donca E., Stone R., Schurman S., Nayir A., Alpay H., Bakka-Loglu A., Rodriguez-Soriano J., Morales J., Sanjad S., Taylor C, Pilz D., Bren A., Trachtman H., Griswold W., Richard G., John E., Lifton R. Mutations in the chloride channel gene, C1CNKB, cause Bartter's syndrome type III. Nature Genet. 1997, 17:171-178.
51. Beyenbach K. Energizing epithelial transport with the vacuolar H+-ATPase. News Physiol. Sci. 2001, 16:145-151.
52. Stapleton F.B. Hematuria associated with hypercalciuria and hyperuricosuria: A practical approach. Pediatr. Nephrol. 1994, 8:756-761.
53. Alon U.S., Berenbom A. Idiopathic hypercalciuria of childhood. Pediatr. Nephrol. 2000, 14:1011-1015.
54. Lawoyin S., Sismilich S., Browne B., Pak C. Bone mineral content in patients with calcium urolithiasis. Metabolism 1979, 28:1250-1254.
55. Lindergard B., Collen S., Mansson W., Rademark C., Rog-Land B. Calcium loading test and bone disease in patients with urolithiasis. Proc. EDTA 1983, 20:460-465.
56. Bataille P., Achard J., Fournier A., Boudailliez B., Westeel P., Esper N., Bergot C., Jans I., Lalau J., Petit J., Henon G., Jeantet M., Bouillon R., Sebert J. Diet, vitamin D, vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int. 1991, 39:1193-1205.
57. Perrone H., Marone M., Bianco A., Toporovski J., Malvestiti L., Schor N. Bone mineral density in hypercalciuric children: A 5 year follow-up [Abstract]. Pediatr. Nephrol. 2002, C121.
58. García-Nieto V., Ferrández C., Monge M., De Sequera M., Rodrigo M. Bone mineral density in pediatric patients with idiopathic hypercalciuria. Pediatr. Nephrol. 1997, 11:578-583.
59. Malluche H., Tschoepe W., Ritz E., Meyer-Sabellek W., Massry S. Abnormal bone histology in idiopathic hypercalciuria. J.Clin. Endocrinol. Metab. 1980, 50:654-658.
60. Zerwekh J., Sakhaee K., Breslau N., Gottschalk F., Pak C. Impaired bone formation in male idiopathic osteoporosis: Further reduction in the presence of concomitant hypercalciuria. Osteoporosis Int. 1992, 2:128-134.
61. Pfeferman-Hejlberg I., Martini L., Szejnfeld V., Carvalho A., Draibe S., Ajzen H., Ramos O., Schor N. Bone disease in calcium stone forming patients. Clin. Nephrol. 1994, 42:175-182.
62. Steiniche T., Mosekilde L., Christensen M., Melsen F. A histomorphometric determination of iliac bone remodeling in patients with recurrent stone formation and idiopathic hypercalciuria. APMIS 1989, 97:309-316.
63. Pacifici R., Rifas L., Teitelbaum S., Slatapolsky E., Mccracken R., Bergfeld M., Lee W., Avioli L., Peck M. Spontaneous release of interleukin-1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc. Natl. Acad. Sci. USA 1987, 84:4616-4620.
64. Weisinger J., Alonzo E., Bellorin-Font C., Blasini A., Rodriguez M., Paz-Martinez V., Martinis R. Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int. 1996, 49:244-250.
65. Borghi L., Schianchi T., Meschi T., Guerra A., Allegri F., Maggiore U., Novarini A. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N.Engl. J. Med. 2002, 346:77-84.
66. Adams J., Song C., Kantorovich V. Rapid recovery of bone mass in hypercalciuric, osteoporotic men treated with hydrochlorothiazide. Ann. Intern. Med. 1999, 130:658-660.
67. Reusz G.S., Dobos M., Tulassay T., Miltenyi M. Hydrochlorothiazide treatment of children with hypercalciuria: Effects and side effects. Pediatr. Nephrol. 1993, 7:699-702.
68. Rodriguez-Soriano J. New insights into the pathogenesis of renal tubular acidosis from functional to molecular studies. Pediatr. Nephrol. 2000, 14:1121-1136.
69. Sly W., Whyte M., Sundaram V., Tashian R., Hewett-Emmett D., Guibaud P., Vainsel M., Baluarte H., Gruskin A., Al-Mosawi M., Sakati N., Ohlsson A. Carbonic anhy-drase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N.Engl. J. Med. 1985, 313:139-145.
70. Nagai R., Kooh S., Balfe J., Fenton T., Halperin M. Renal tubular acidosis and osteopetrosis with carbonic anhydrase II deficiency: Pathogenesis of impaired acidification. Pediatr. Nephrol. 1997, 11:633-636.
71. Lemann J., Adams N., Wilz D., Brenes L. Acid and mineral balances and bone in familial proximal renal tubular acidosis. Kidney Int. 2000, 58:1267-1277.
72. Rodriguez-Soriano J., Vallo A. Renal tubular acidosis. Pediatr. Nephrol. 1990, 4:268-275.
73. 2. Pediatr. Nephrol. 1991, 5:307-311.
74. Brenner R., Spring D., Sebastian A., Mcsherry E., Genant H., Palubinskas A., Morris J.R. Incidence of radiograph-ically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis. N.Engl. J. Med. 1982, 307:217-221.
75. Chesney R.W., Kaplan B., Phelps M., Deluca H. Renal tubular acidosis does not alter circulating values of calcitriol. J.Pediatr. 1984, 104:51-55.
76. Coe F., Firpo J. Evidence for mild reversible hyper-parathyroidism in distal renal tubular acidosis. Arch. Intern. Med. 1975, 135:1485-1489.
77. Richards P., Chamberlain M., Wrong O. Treatment of osteomalacia of renal tubular acidosis by sodium bicarbonate alone. Lancet 1972, 11:994-997.
78. Harrington T., Bunch T., Van Den Berg C. Renal tubular acidosis: A new look at treatment of musculoskeletal and renal disease. Mayo Clinic Proc. 1983, 58:354-360.
79. Domrongkitchaiporn S., Pongsakul C., Stitchantrakul W., Siri-Kulchayanonta V., Ongphiphadhanakul B., Radinahamed P., Karnsombut P., Kunkitti N., Ruangraksa C., Rajatanavin R. Bone mineral density and histology in distal renal tubular acidosis. Kidney Int. 2001, 59:1086-1093.
80. Weger W., Kotanko P., Weger M., Deutschmann H., Skrabal F. Prevalence and characterization of renal tubular acidosis in patients with osteopenia and osteoporosis in non-porotic controls. Nephrol. Dial. Transplant. 2000, 15:975-980.